Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genelux Corporation
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
AbbVie
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
AGO Study Group
Hoffmann-La Roche
Seoul National University Hospital
Hoffmann-La Roche
AGO Study Group
National Cancer Institute (NCI)
Genentech, Inc.
National Cancer Institute (NCI)